SCHEMBL19734612

SCHEMBL19734612

COc1cc(/C=C/c2ccc(OCc3ccccc3)c(OC)c2)ccc1OCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 8/20 0.70
HPGD P15428 4/20 0.65
ALDH1A1 P00352 3/20 0.65
HTT P42858 2/20 0.65
KDM4E B2RXH2 2/20 0.65
CYP1A1 P04798 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP1B1 Q16678 1/20 0.65
HDAC3 O15379 1/20 0.63
HDAC4 P56524 1/20 0.63
HDAC1 Q13547 1/20 0.63
HDAC7 Q8WUI4 1/20 0.63
HDAC2 Q92769 1/20 0.63
HDAC10 Q969S8 1/20 0.63
HDAC11 Q96DB2 1/20 0.63
HDAC8 Q9BY41 1/20 0.63
HDAC6 Q9UBN7 1/20 0.63
HDAC9 Q9UKV0 1/20 0.63
HDAC5 Q9UQL6 1/20 0.63
MEN1 O00255 2/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9587050 0.94 CYP1A1 (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL9587052 0.94 CYP1A1 (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL13991619 0.93 PDCD1 (0.68) APPHPGDALDH1A1HTTKDM4E
SCHEMBL28452059 0.93 APP (0.62) APPHPGDALDH1A1HTTKDM4E
SCHEMBL891624 0.92 APP (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL29529587 0.92 APP (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL873590 0.92 APP (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL14763980 0.92 APP (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL3271115 0.92 APP (0.65) APPHPGDALDH1A1HTTKDM4E
SCHEMBL19728204 0.92 APP (0.61) APPHPGDALDH1A1HTTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170362152-A1 NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF L'OREAL (FR) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170362152-A1 NOVEL 1,2-DIPHENYLETHYLENE GLYCOL COMPOUNDS FOR COMBATING AGING OF THE SKIN, AND COSMETIC USE THEREOF GLA, DSG1, GPX1 APP 1876/4885HPGD 72/4885ALDH1A1 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.